Kasner S E, Villar-Cordova C E, Tong D, Grotta J C
University of Pennsylvania Medical Center, Philadelphia, USA.
Neurology. 1998 Jun;50(6):1857-9. doi: 10.1212/wnl.50.6.1857.
Hemorrhage is the major complication of IV recombinant tissue plasminogen activator (rt-PA) treatment for stroke. We report three patients with mild or indistinct cardiac symptoms prior to thrombolysis in whom hemodynamically significant cardiac tamponade occurred after treatment with rt-PA. Acute ischemic stroke patients may have undetected myocardial or pericardial disease that may pose a risk for hemopericardium and life-threatening tamponade after treatment with rt-PA.